Quipt Home Medical to Ring Nasdaq Opening Bell on September 2, 2021
Quipt Home Medical Corp. (NASDAQ:QIPT) will ring the Nasdaq Opening Bell on September 2, 2021, in celebration of its recent listing. CEO Greg Crawford highlighted the achievement as a milestone for the company and its over 600 employees. Quipt has experienced significant growth, adding 25,000 active patients and generating over $11 million in revenue across four new states in the last two months. The company aims to expand its offerings in chronic disease management while enhancing shareholder value by increasing annual revenue per patient.
- Added 25,000 active patients in two months.
- Generated over $11 million in revenue recently.
- Expanded services into 4 new states.
- Recent Nasdaq listing is a significant milestone.
- None.
CINCINNATI, Sept. 01, 2021 (GLOBE NEWSWIRE) -- Quipt Home Medical Corp. (the “Company” or “Quipt”) (NASDAQ:QIPT; TSXV:QIPT), a U.S. based leader in the home medical equipment industry, focused on end-to-end respiratory care, today announced that the Quipt Team, together with Greg Crawford, Chairman and CEO, will ring the Nasdaq Opening Bell on Thursday, September 2, 2021, in celebration of Quipt’s listing on Nasdaq on May 27, 2021. The ceremony will begin at approximately 9:15 am (ET) and can be viewed live at https://www.nasdaq.com/marketsite/bell-ringing-ceremony.
“We are extremely proud to ring the opening bell of Nasdaq, honouring our recent listing on this prestigious exchange. The Nasdaq listing is an incredible achievement for our over 600 employees and longstanding shareholders, as we continue our mission of providing superior patient care for at home respiratory patients across the United States,” said Greg Crawford, Chairman and CEO of Quipt. “Joining an exchange that is home to some of the most disruptive companies in the world reflects the continued growth across our organization and our evolution as a publicly traded company over the last several years. We are proud of the robust expansion achieved to date, including the addition of 25,000 active patients, over
ABOUT QUIPT HOME MEDICAL
The Company provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offerings to include the management of several chronic disease states focusing on patients with heart or pulmonary disease, sleep disorders, reduced mobility and other chronic health conditions. The primary business objective of the Company is to create shareholder value by offering a broader range of services to patients in need of in-home monitoring and chronic disease management. The Company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating the patient’s services and making life easier for the patient.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information please visit our website at www.quipthomemedical.com, or contact:
Cole Stevens
VP of Corporate Development
Quipt Home Medical Corp.
859-300-6455
cole.stevens@myquipt.com
Gregory Crawford
Chief Executive Officer
Quipt Home Medical Corp.
859-300-6455
investorinfo@myquipt.com
FAQ
What is the significance of Quipt's Nasdaq opening bell ringing on September 2, 2021?
How many active patients did Quipt add in the last two months?
What revenue did Quipt report recently?
How has Quipt expanded its operations recently?
What is Quipt's focus in the home medical equipment industry?
